EP3604532

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP19171732A
Filing Date
Jun 17, 2016
Status
Granted And Under Opposition
Mar 29, 2024
Grant Date
May 1, 2024
External Links
Slate, Register

Biblio Summary

The patent EP3604532B1 was granted on May 1, 2024 by Massachusetts Institute Of Technology The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GRUND IPG PATENTANWALTE UND SOLICITOR PARTG MBBNov 13, 2024 N.A.

The table below shows the patents of Massachusetts Institute Of Technology that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3294873Targeting Bcl11A Enhancer Functional Regions For Fetal Hemoglobin ReinductionSep 18, 20241
EP3237615Crispr Having Or Associated With Destabilization DomainsJul 26, 20232
EP2306616Wireless Non-Radiative Energy TransferJun 21, 20231

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.